Literature DB >> 33059962

Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome.

Delbar Daneshjou1, Malek Soleimani Mehranjani2, Shahrzad Zadeh Modarres3, Mohammad Ali Shariatzadeh1.   

Abstract

Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving different aspects of PCOS.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  metformin; polycystic ovarian syndrome; sitagliptin

Year:  2020        PMID: 33059962     DOI: 10.1016/j.tem.2020.09.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  4 in total

Review 1.  Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials.

Authors:  Lijuan Zhang; Airong Chen; Jing Lu; Liuliu Ren; Zelin Hu
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

Review 2.  The Effects of the New Therapeutic Treatments for Diabetes Mellitus on the Male Reproductive Axis.

Authors:  Carla Pelusi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-20       Impact factor: 6.055

3.  The Protective Effects of Trans-Anethole against Polycystic Ovary Syndrome Induced Histopathological and Metabolic Changes in Rat.

Authors:  Faezeh Moradi Negahdari; Mousa-Al-Reza Hadjzadeh; Zahra Gholamnezhad; Farzaneh Sohrabi; Zahra Samadi Noshahr
Journal:  Int J Fertil Steril       Date:  2022-08-21

Review 4.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.